Kandori Hitoshi, Suzuki Shugo, Asamoto Makoto, Murasaki Toshiya, Mingxi Tang, Ogawa Kumiko, Shirai Tomoyuki
Department of Experimental Pathology and Tumor Biology, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya 467-8601, Japan.
Cancer Sci. 2005 Apr;96(4):221-6. doi: 10.1111/j.1349-7006.2005.00041.x.
Atrazine, which has been used worldwide as a pesticide, is now known to exert endocrine disrupting (antiandrogenic) effects in mammals. In this study, modifying effects of dietary feeding of 500 and 1000 p.p.m. atrazine on the development of androgen-dependent prostate cancer were investigated using male probasin/SV40 T antigen transgenic (TG) rats. As administration of atrazine has now been identified as causing a decrease in bodyweight, a dietary-restricted TG rat group was also included in order to elucidate the influence of reduction of calorie intake per se on the development of prostate cancer. At week 13, almost the entire lobes of the prostate were occupied with tumor lesions, with no clear intergroup differences in the incidences and multiplicities. Therefore, morphometrical assessment ratios of the prostate epithelial area to the whole prostate tissue area were evaluated. The ratio in the lateral lobe of the 1000 p.p.m. atrazine-treated group was significantly decreased, and there was a tendency to decrease in the ratios in the dorsal lobe of the atrazine-treated groups. However, dietary restriction itself without atrazine treatment caused the same reduction to a similar or greater extent. Testosterone levels were not affected by atrazine administration or dietary restriction. Our results indicate that the observed atrazine-related suppression of prostate carcinogenesis was probably caused by the decrease in calorie intake, rather than by atrazine-related endocrine disruption.
阿特拉津作为一种杀虫剂已在全球范围内使用,现在已知其在哺乳动物中具有内分泌干扰(抗雄激素)作用。在本研究中,使用雄性前列腺素/SV40 T抗原转基因(TG)大鼠,研究了饮食中添加500和1000 ppm阿特拉津对雄激素依赖性前列腺癌发展的调节作用。由于现已确定阿特拉津的给药会导致体重下降,因此还纳入了饮食限制的TG大鼠组,以阐明热量摄入减少本身对前列腺癌发展的影响。在第13周时,几乎整个前列腺叶都被肿瘤病变占据,各组之间在发病率和肿瘤数量上没有明显差异。因此,评估了前列腺上皮面积与整个前列腺组织面积的形态计量学评估比率。1000 ppm阿特拉津处理组侧叶的比率显著降低,阿特拉津处理组背叶的比率有降低的趋势。然而,未经阿特拉津处理的饮食限制本身也导致了类似或更大程度的降低。睾酮水平不受阿特拉津给药或饮食限制的影响。我们的结果表明,观察到的与阿特拉津相关的前列腺癌发生抑制可能是由热量摄入减少引起的,而不是由阿特拉津相关的内分泌干扰引起的。